云南高校图书馆联盟文献共享服务平台- BIOSIMILARS

检索规则说明：AND代表“并且”；OR代表“或者”；NOT代表“不包含”；(注意必须大写,运算符两边需空一格)

检索范例：范例一： (K=图书馆学 OR K=情报学) AND A=范并思　　　　范例二：J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual

全部期刊核心期刊 EI来源期刊 SCI来源期刊 CA来源期刊 CSCD来源期刊 CSSCI来源期刊

The impact potential of aflibercept biosimilars: 《Annals of Eye Science》2025年第1期22-25,共4页Adrienne Delaney Peter K.Kaiser; A biologic drug is a medication produced from or containing components of living organisms.Given the rigorous testing that originator biologics undergo to establish Food and Drug Administration(FDA)Biologics License A...; 关键词：BIOSIMILAR MYL-1701P BIOLOGIC ANTI-VEGF diabetic macular edema(DME)

Comparison and Suggestions on the Registration and Regulation of Biosimilars between China and the USA: 《Asian Journal of Social Pharmacy》2025年第1期28-37,共10页Cao Yizhi Lian Guiyu; Objective To put forward some suggestions for improving the registration and regulation,the efficiency of evaluation,and approval of biosimilar in China so as to promote the development of biopharmaceutical industry a...; 关键词：BIOSIMILAR registration and regulation REVIEW approve

Effectiveness and safety of biosimilars in pediatric inflammatory bowel diseases:an observational longitudinal study on the French National Health Data System: 《World Journal of Pediatrics》2025年第1期62-72,共11页Hugo Jourdain Léa Hoisnard Emilie Sbidian Mahmoud Zureik; Background Data on biosimilar use in pediatric inflammatory bowel diseases(IBD)are scarce compared to the status of studies in adults,resulting in limitations in its treatment.We compared effectiveness and safety of b...; 关键词：Biosimilar pharmaceuticals Cohort studies Inflammatory bowel diseases PEDIATRICS Routinely collected health data

Real-world experience and long-term outcomes of a mandatory nonmedical switch of adalimumab originator to biosimilars in inflammatory bowel disease: 《World Journal of Gastroenterology》2024年第46期4904-4913,共10页Jeremy Liu Chen Kiow Thomas Hoang Harjot K Bedi Zhina Majdzadeh Ardekani Daniel Rosenfeld Marica Reise-Filteau Brian Bressler Yvette Leung Greg Rosenfeld; BACKGROUND Over the last decade,the treatment options for inflammatory bowel disease(IBD)have significantly progressed with the emergence of new medications designed to target various immune pathways and mitigate infl...; 关键词：Inflammatory bowel disease Ulcerative colitis Crohn’s disease BIOLOGICS ADALIMUMAB Biosimilar switch

Uptake of biosimilars in China:a retrospective analysis of the case of trastuzumab from 2018 to 2023: 《Global Health Research and Policy》2024年第1期139-150,共12页Qiyou Wu Zhitao Wang Yihan Fu Ren Luo Jing Sun; Peking Union Medical College[Fund(2019)No.22]。; Background The Chinese biosimilar industry has demonstrated rapid growth in recent years.Limited evidence is available about biosimilar uptake at the national level.This study aimed to assess biosimilar uptake in the ...; 关键词：BIOSIMILARS TRASTUZUMAB Market dynamics Market competitions UPTAKE

Cancer treatment with biosimilar drugs:A review: 《Cancer Innovation》2024年第2期45-62,共18页Shilpa Malakar Emmanuel Nuah Gontor Moses YDugbaye Kamal Shah Sakshi Sinha Priya Sutaoney Nagendra Singh Chauhan; Director of AYUSH(Chhattisgarh)for laboratory facilities and National Ayush Mission(NAM)Grant award year 2016-17。; Biosimilars are biological drugs created from living organisms or that contain living components.They share an identical amino-acid sequence and immunogenicity.These drugs are considered to be cost-effective and are u...; 关键词：BIOLOGICS BIOSIMILARS cancer Escherichia coli monoclonal antibody next-generation sequencing PHARMACOVIGILANCE

Analytical Method Development and Validation of Some Biosimilar Drugs by High Performance Thin Layer Chromatography: 《American Journal of Analytical Chemistry》2023年第3期121-133,共13页Husna Kanwal Qureshi Ciddi Veeresham; A simple and rapid HPTLC analytical method has been developed and validated for the determination of Etanercept and Filgrastim in pure form and in marketed formulation. Both the drugs were chromatographed on silica ge...; 关键词：BIOSIMILARS ETANERCEPT FILGRASTIM Method Development Validation

Familiarity, Knowledge and Practices of Healthcare Professionals Regarding the Pharmacovigilance of Biological Medicines in Lusaka, Zambia: A Multi-Facility Cross-Sectional Study: 《Pharmacology & Pharmacy》2022年第7期230-251,共22页Michelo Banda Katia Verhamme Webrod Mufwambi Steward Mudenda Billy Chabalenge Scott Kaba Matafwali Ronald Kampamba Mutati Christabel Nang’andu Hikaambo Martin Kampamba Lavina Prashar; Background: Pharmacovigilance of biological medicines is crucial because it ensures that medicines meet the World Health Organization (WHO) standards. In Zambia, there is little information on healthcare professionals...; 关键词：PHARMACOVIGILANCE Biological Medicines BIOSIMILARS BRAND BATCH Zambia

Emerging role of biosimilars in the clinical care of inflammatory bowel disease patients: 《World Journal of Clinical Cases》2022年第14期4327-4333,共7页Hala Najeeb Farah Yasmin Salim Surani; The increasing incidence of inflammatory bowel disease(IBD)globally has redirected the healthcare system's focus towards safe and affordable pharmacological interventions.The inception of anti-tumor necrosis factor-α...; 关键词：Inflammatory bowel disease BIOSIMILARS Anti-tumor necrosis factor INFLIXIMAB ADALIMUMAB Ulcerative colitis Chrons disease

Analytical Method Development and Validation of Etanercept by UV and RP-UFLC Methods: 《American Journal of Analytical Chemistry》2021年第12期493-505,共13页Husna Kanwal Qureshi Ciddi Veeresham Chinta Srinivas; The research work was carried out using Ultraviolet (UV)—visible spectroscopy and Reverse Phase-Ultra Fast Liquid Chromatography (RP-UFLC) for establishing novel methods for the analysis and quantification of Biosimi...; 关键词：BIOSIMILARS ETANERCEPT Etacept^® RP-UFLC UV Spectroscopy VALIDATION

BIOSIMILARS